Advertisement

Topics

Latest "Saccharomyces Cerevisiae Strain Comparison Glucose Xylose Fermentations Defined" News Stories

20:26 EDT 17th June 2018 | BioPortfolio

Here are the most relevant search results for "Saccharomyces Cerevisiae Strain Comparison Glucose Xylose Fermentations Defined" found in our extensive news archives from over 250 global news sources.

More Information about Saccharomyces Cerevisiae Strain Comparison Glucose Xylose Fermentations Defined on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Saccharomyces Cerevisiae Strain Comparison Glucose Xylose Fermentations Defined for you to read. Along with our medical data and news we also list Saccharomyces Cerevisiae Strain Comparison Glucose Xylose Fermentations Defined Clinical Trials, which are updated daily. BioPortfolio also has a large database of Saccharomyces Cerevisiae Strain Comparison Glucose Xylose Fermentations Defined Companies for you to search.

Showing "Saccharomyces Cerevisiae Strain Comparison Glucose Xylose Fermentations Defined" News Articles 1–25 of 2,100+

Saturday 16th June 2018

What is Disease X? Deadly Bird Flu Virus Could Be Next Pandemic – Yahoo News UK

Yahoo News UKWhat is Disease X? Deadly Bird Flu Virus Could Be Next PandemicYahoo News UKA deadly new strain of bird flu threatens to become a worldwide pandemic, health officials warn. Britain's deputy chief medical officer Jonathan Van-Tam says the strain, which has already killed one-third of infected patients in China, could be the ...Disease X killer bird flu strain could cause global pandemi...


Friday 15th June 2018

Blueprint Avapritinib Demonstrates Profound and Durable Clinical Activity in Advanced Systemic Mastocytosis Trial

CAMBRIDGE, Mass., June 15, 2018 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced updated data from its ongoing Phase 1 EXPLORER clinical trial of avapritinib, a potent and highly selective KIT and PDGFRA inhibitor in development for patients with...

Johnson & Johnson sells LifeScan to Platinum Equity

Global pharmaceutical company Johnson & Johnson has accepted investment firm Plantinum Equity’s offer to acquire LifeScan, its blood glucose monitoring...Read More... The post Johnson & Johnson sells LifeScan to Platinum Equity appeared first on Pharmaceutical Technology.


Where Next For Digital Support Programs?

Is the pharma business model broken? How will pharma firms deliver true value and relevance in the years ahead? What is the step change required? These questions were at the back of my mind when S3 Connected Health and eyeforpharma were working on our joint white paper, Patient Support Programs: Now, Near, Next. We wanted to take the pulse of industry experts on their ‘beyond the pill’ strateg...

Novartis study of real-world data concludes Jakavi is associated with a reduction in risk of death and dangerous blood clots for patients with rare blood cancer

Novartis International AG / Novartis study of real-world data concludes Jakavi is associated with a reduction in risk of death and dangerous blood clots for patients with rare blood cancer . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Comparison of Jakavi® (ruxolitinib) vs. best available...

BioTel Care Unveils Next-Gen Wireless Blood Glucose Monitor for Diabetes Management

BioTel CareTM (formally known as Telcare), a BioTelemetry company has announced the release of its next-generation wireless blood glucose monitor for diabetes management. BioTel Care developed the first FDA-cleared, cellular-enabled glucometer which supports real-time transmission and consolidation of patient data in an FDA-cleared cloud.   Building on the success of this technology, BioTel Care ...

Thursday 14th June 2018

[Articles] Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial

In patients with severe metabolic acidaemia, sodium bicarbonate had no effect on the primary composite outcome. However, sodium bicarbonate decreased the primary composite outcome and day 28 mortality in the a-priori defined stratum of patients with acute kidney injury.

Frequently Enjoying Kimchi Decreases Body Fat and Suppresses Obesity-Related Complications

- Animal studies prove that lactic acid bacteria in kimchi reduce body fat and prevent obesity-related complications - This is the result of two separate studies led by Dr. Hak-Jong Choi of the World Institute of Kimchi (WiKim) and Dr. Yang-Hoon Kim of Chungbuk National University in which lactic acid bacteria, isolated from kimchi, were fed to obesity-induced mice SEOUL, South Korea, June 14, ...

Medicare Shoppers Award eHealth an Impressive Net Promoter Score of 91, Demonstrating Outstanding Customer Loyalty

Between 2016 and the first quarter of 2018, eHealth improved its Net Promoter Score with Medicare customers from 73 to 91 A strong commitment to comprehensively serving the needs of Medicare insurance shoppers pays off, according to the results of a Net Promoter Score (NPS) survey published today by eHealth, Inc. (NASDAQ: EHTH) (eHealthMedicare.com and...

Syros Announces Appointment of Michael W. Bonney to Its Board of Directors

Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of genes, today announced the appointment of Michael W. Bonney to the Company’s Board of Directors. Mr. Bonney brings extensive strategic, operational, commercial and leadership experience in the biotechnology industr...

Specialists Rethink Lung Cancer Treatment Plans, With Eye On IO Biomarkers

Plenary speaker at this year's meeting, Leena Gandhi, envisioned a future where individual patients receive a precisely defined immunotherapy regimen.   

J&J seals deal on purchase of major diabetes devices firm

A deal worth $2.1 billion has been struck between Johnson & Johnson (J&J) and the firm behind the world-leading glucose monitoring system. Platinum Equity, whose business LifeScan Inc makes the OneTouch devices, made the binding offer to J...

J&J seals $2.1bn deal on sale of major diabetes devices firm

As part of its ongoing divestment program, a deal worth $2.1 billion has been struck between Johnson & Johnson (J&J) and US private equity firm Platinum Equity over the sale of the company responsible for the world's leading glucose monitorin...

A Leading Diabetes Drugs Manufacturer Understood the Effectiveness of Clinical Trials against Real-World Data | Quantzig

Quantzig, a global analytics solutions provider, has announced the completion of their latest patient journey analysis study on the diabetes drugs manufacturer. The client, a diabetes drugs manufacturer wanted to authenticate the efficiency of their clinical trials by understa

Probiotic, Live Vaccine Both Curb Cholera

New probiotic and vaccine-based interventions have been shown to suppress cholera in animal models, indicated two research articles, both of which appeared June 13 in the journal Science Translational Medicine . The probiotic intervention, developed by a team of scientists based at MIT, consists of a mix of natural and engineered Lactococcus bacteria. The vaccine-based intervention, developed by a...

ArQule to Present at The JMP Securities Life Sciences Conference on June 21, 2018

ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, will present at The JMP Securities Life Sciences Conference on June 21, 2018, at 10:30am EDT at the St. Regis in New York. The live webcast of the presentation will be available ...

Apply for Award in Bioanalytical Chemistry

The Ralph N. Adams Award in bioanalytical Chemistry will be presented at Pittcon 2019 and includes a cash award and travel expenses. The award recognizes significant contributions to the field of bio-analytical chemistry, broadly defined. The recipient will have introduced a significant technique, theory, instrument or application important to the life sciences, and provided an exceptional environ...

CMS OKs Medicare coverage for continuous glucose monitors used with apps

The CMS announced it will update Medicare's coverage policy for continuous glucose monitors for diabetes to include the use o -More- 

Clinigen Signs Exclusive Supply & Distribution Agreement with Lukare for Elliotts B® Solution

Burton-on-Trent, England, June 14, 2018 / B3C newswire / -- Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has signed an exclusive agreement with Lukare Medical (‘Lukare’) to manage the supply and distribution of Elliotts B® Solution. Under the terms of this supply and distribution agreement with Lukare, Clinigen will provide physicians and ph...

The Health Management Academy Analyzes Intra-Company Logistics in Recent Survey

The Health Management Academy (The Academy) announced the release of its most recent survey—an analysis of intra-company logistics at leading U.S. health systems. ALEXANDRIA, Va. (PRWEB) June 14, 2018 The Health Management Academy (The Academy) announced the release of its most recent survey —an analysis of intra-company logistics at leading U.S. health systems. The quantitative survey polled...

 Winter crisis is now year-long crisis, suggests new NHS Confederation report

Regulators should use discretion when considering whether to withhold extra funding from health and care organisations, the NHS Confederation says in a new report. The report, System under Strain, shows how increasing year-on-year demand, coupled with flat funding, is not just a winter phenomenon affecting accident and emergency departments. The report highlights how demand and […] The post ...

SOMMEIL : L’exposition à la lumière la nuit chamboule le métabolisme

Une seule nuit d'exposition à la lumière pendant le sommeil a un impact important sur les mesures de résistance à l'insuline. Or de la tolérance au glucose vs la résistance à l’insuline dépend notre santé métabolique. Et la résistance à l’insuline précède le développement du diabète de type 2. Des données présentées au Congrès SLEEP […]

Wednesday 13th June 2018

History of modern nutrition science—implications for current research, dietary guidelines, and food policy

Although food and nutrition have been studied for centuries, modern nutritional science is surprisingly young. The first vitamin was isolated and chemically defined in 1926, less than 100 years ago,...

Pharmacists intervention improves management of diseases among Syrian refugees in Jordan

(Elsevier) As global political conflicts continue, refugees are facing challenges such as the unavailability of proper medical care. Many of the Syrian refugees now living in Jordan are struggling with chronic diseases, placing tremendous strain on existing health and humanitarian resources as a result. A new study published in Research in Social and Administrative Pharmacy demonstrates that pharm...

Proteins as a 'shuttle service' for targeted administration of medication

(University of Erlangen-Nuremberg) Medication that reaches the spot where it's needed without placing strain on the rest of the body is no longer a vision of the future. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) has successfully developed proteins that function like a shuttle and release medication directly in the place in the body where they are actually needed. The study could se...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks